ASSET PURCHASE AGREEMENT by and between THREE RIVERS PHARMACEUTICALS, LLC (as Buyer) and VALEANT PHARMACEUTICALS NORTH AMERICA (as Seller) December 19, 2007Asset Purchase Agreement • March 17th, 2008 • Valeant Pharmaceuticals International • Pharmaceutical preparations • New York
THIS ASSET PURCHASE AGREEMENT (together with all annexes, exhibits, schedules and other documents attached hereto, hereinafter referred to as the (“Agreement”) dated as of December 19, 2007 (the “Execution Date”) is made by and between Valeant Pharmaceuticals North America, a Delaware corporation (“Seller”), and Three Rivers Pharmaceuticals, LLC, a Pennsylvania limited liability company (“Buyer”). Capitalized terms used herein and not otherwise defined shall have the meanings set forth in Section 9.1 hereof.
January 11, 2008 Three Rivers Pharmaceuticals, LLC 301 Commerce Park Drive Cranberry Township, PA 16066 Ladies and Gentlemen:Asset Purchase Agreement • March 17th, 2008 • Valeant Pharmaceuticals International • Pharmaceutical preparations • New York
Reference is made to the Asset Purchase Agreement (the “Agreement”) dated as of December 19, 2007 by and between Valeant Pharmaceuticals North America (“Seller”) and Three Rivers Pharmaceuticals, LLC (“Buyer”). Capitalized terms used herein without definition shall have the meaning ascribed to them in the Agreement.
SEPARATION AND RELEASE AGREEMENT RecitalsSeparation and Release Agreement • March 17th, 2008 • Valeant Pharmaceuticals International • Pharmaceutical preparations • California
